Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, et al. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320(10):984–94. https://doi.org/10.1001/jama.2018.12163

Article  CAS  PubMed  PubMed Central  Google Scholar 

Månsson TS, Askemyr A, Sunnerhagen T, Tham J, Riesbeck K, Mellhammar L. Piperacillin/tazobactam versus carbapenems for 30-day mortality in patients with ESBL-producing enterobacterales bloodstream infections: a retrospective, multicenter, non-inferiority, cohort study. Infection. 2025;16. https://doi.org/10.1007/s15010-025-02496-x

Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55. https://doi.org/10.1093/biomet/70.1.41

Article  Google Scholar 

Shamsrizi P, Gladstone BP, Carrara E, Luise D, Cona A, Bovo C, et al. Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis. BMJ Open. 2020;10(1):e030266. https://doi.org/10.1136/bmjopen-2019-030266

Article  PubMed  PubMed Central  Google Scholar 

Sarkari NN, Perman SM, Ginde AA. Impact of early do-not-attempt-resuscitation orders on procedures and outcomes of severe sepsis. J Crit Care. 2016;36:134–9. https://doi.org/10.1016/j.jcrc.2016.06.030

Article  PubMed  PubMed Central  Google Scholar